OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Hunan Nucien Pharmaceutical Co OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Hunan Nucien Pharmaceutical Co OCF Yield % Related Terms
Hunan Nucien Pharmaceutical Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Nucien Pharmaceutical Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hunan Nucien Pharmaceutical Co OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hunan Nucien Pharmaceutical Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Hunan Nucien Pharmaceutical Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hunan Nucien Pharmaceutical Co (SHSE:688189) has a OCF Yield % of 0.19 as of Jul. 09, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Hunan Nucien Pharmaceutical Co and its competitors. According to the industry distribution chart, Hunan Nucien Pharmaceutical Co ranks #691 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 68.6%.
Is Hunan Nucien Pharmaceutical Co's OCF Yield % too high?
Hunan Nucien Pharmaceutical Co's current OCF Yield % is 0.19. The Drug Manufacturers industry median OCF Yield % is 3.53. Hunan Nucien Pharmaceutical Co's value of 0.19 is 94.6% below this industry median. Based on the distribution chart, Hunan Nucien Pharmaceutical Co ranks #691 out of 1007 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Hunan Nucien Pharmaceutical Co has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hunan Nucien Pharmaceutical Co's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hunan Nucien Pharmaceutical Co ranks #691 out of 1007 companies for OCF Yield %. This places Hunan Nucien Pharmaceutical Co in the lower half of its industry. The industry median OCF Yield % is 3.53. Hunan Nucien Pharmaceutical Co's value of 0.19 is 94.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.53, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hunan Nucien Pharmaceutical Co's current OCF Yield % of 0.19 is 94.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Hunan Nucien Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hunan Nucien Pharmaceutical Co's current OCF Yield % is 0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hunan Nucien Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co (SHSE:688189) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥2.36, compared to a current price of ¥6.30 — trading 166.9% above its estimated fair value. The current OCF Yield % is 0.19 and 94.6% below the Drug Manufacturers industry median of 3.53. Hunan Nucien Pharmaceutical Co's overall GF Score™ is 52/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Hunan Nucien Pharmaceutical Co (SHSE:688189), the current OCF Yield % is 0.19 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hunan Nucien Pharmaceutical Co (SHSE:688189) Overvalued in 2026?
Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥6.30 is trading 166.9% above its estimated GF Value™ of ¥2.36.
GuruFocus considers Hunan Nucien Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for SHSE:688189:
OCF Yield %: 0.19
GF Value™: ¥2.36 vs. price of ¥6.30 (166.9% above fair value)
Industry Position: 94.6% below the Drug Manufacturers median (#691 of 1007)
No single metric tells the full story. See the SHSE:688189 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hunan Nucien Pharmaceutical Co Business Description
Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields. The company's business scope includes the manufacturing and sales of chemical pharmaceutical preparations, chemical pharmaceutical raw materials, biological drugs, chemical reagents, and auxiliaries.
52GF Score
Get the complete analysis for SHSE:688189
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688189 has been successfully added to your 
